| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/06/2003 | EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
| 08/06/2003 | EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity |
| 08/06/2003 | EP0865419B1 Indane dimer compounds and their pharmaceutical use |
| 08/06/2003 | EP0821691B1 Methods of synthesizing gm2 |
| 08/06/2003 | EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists |
| 08/06/2003 | EP0687182B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3 |
| 08/06/2003 | CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434818A Novel compounds |
| 08/06/2003 | CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 08/06/2003 | CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/06/2003 | CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors |
| 08/06/2003 | CN1434799A Cyclic amp-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 08/06/2003 | CN1434794A Adamantane derivatives |
| 08/06/2003 | CN1434727A Anglogenesis and vascular permeability modulators and inhibitors |
| 08/06/2003 | CN1434723A Immunostimulatory oligodeoxynucleotides |
| 08/06/2003 | CN1434718A Activation and inhibition of immune system |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/06/2003 | CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose |
| 08/06/2003 | CN1433811A Use of bifidobacterium cell wall and bifidobacterium cell wall protein in pharmacy |
| 08/06/2003 | CN1433770A Use of BCG polysaccharide and Nucleic acid preparation in preparation of medicine for oral cavity local medication |
| 08/06/2003 | CN1117155C Novel compounds |
| 08/06/2003 | CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/06/2003 | CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 08/06/2003 | CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 08/06/2003 | CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 08/06/2003 | CN1116898C Oral immune globulin preparation and its preparing process |
| 08/05/2003 | US6603046 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. |
| 08/05/2003 | US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/05/2003 | US6602885 Viricides, organ transplants, antiarthritic agents |
| 08/05/2003 | US6602883 Inhibitors of farnesyl protein transferase |
| 08/05/2003 | US6602881 Anti-inflammatory uses of manzamines |
| 08/05/2003 | US6602705 Expression of HIV polypeptides and production of virus-like particles |
| 08/05/2003 | US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides |
| 08/05/2003 | US6602509 Compound and method for the prevention and/or the treatment of allergy |
| 08/05/2003 | US6602506 Immunogenic composition; bactericidal |
| 08/05/2003 | US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1 |
| 08/05/2003 | US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions |
| 08/05/2003 | US6602274 Targeted transcutaneous cancer therapy |
| 08/05/2003 | CA2079374C (bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 07/31/2003 | WO2003062467A2 Tissue rejection |
| 07/31/2003 | WO2003062392A2 Methods of treating conditions associated with an edg receptor |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062276A2 Multimers of receptor-binding ligands |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062248A2 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/31/2003 | WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 07/31/2003 | WO2003062232A1 Derivatives of thiazoles used for the treatment of neurological diseases |
| 07/31/2003 | WO2003062200A2 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 07/31/2003 | WO2003062189A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003061703A1 Methods for treatment of multiple sclerosis with statins |
| 07/31/2003 | WO2003061702A1 Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunsuppressor and anti-inflammatory agent |
| 07/31/2003 | WO2003061699A1 Remedies for allergic diseases |
| 07/31/2003 | WO2003061683A1 Peptides for enhancing resistance to microbial infections |
| 07/31/2003 | WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/31/2003 | WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 07/31/2003 | WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | WO2003061634A1 Sustained release pharmaceutical composition |
| 07/31/2003 | WO2003061629A2 Dna dosage forms |
| 07/31/2003 | WO2003061626A1 Polymeric gel system for the controlled delivery of codrugs |
| 07/31/2003 | WO2003061620A2 Peptide-carrying bodies for immune response |
| 07/31/2003 | WO2003061590A2 Peptide constructs for treating disease |
| 07/31/2003 | WO2003061589A2 Methods for treating diseases or conditions with peptide constructs |
| 07/31/2003 | WO2003061587A2 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 07/31/2003 | WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 07/31/2003 | WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof |
| 07/31/2003 | WO2003045978A3 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003039460A3 Mitotic kinesin inhibitors |
| 07/31/2003 | WO2003035679A3 Molecules |
| 07/31/2003 | WO2003035668A3 Novel anti-inflammatory androstane derivatives -17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 07/31/2003 | WO2003014702A3 Uses of mammalian cytokine; related reagents |
| 07/31/2003 | WO2003006016A3 Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury |
| 07/31/2003 | WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 07/31/2003 | WO2003001891A3 Method and apparatus for computer modeling of an adaptive immune response |
| 07/31/2003 | WO2002101005A3 A g-protein coupled receptor and uses therefor |
| 07/31/2003 | WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 07/31/2003 | WO2002094202B1 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 07/31/2003 | WO2002068421A3 Tricyclic compounds and their analogs as inhibitors of cytokine signaling |
| 07/31/2003 | WO2002064627A3 Crystallization of igf-1 |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002060464A3 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use |
| 07/31/2003 | WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |
| 07/31/2003 | WO2002018361A3 Compounds having activity as inhibitors of cytochrome p450rai |
| 07/31/2003 | WO2002012286A3 Stress proteins and peptides and methods of use thereof |
| 07/31/2003 | US20030144529 Treating p38 kinase mediated disorders. Compounds of particular interest are defined by Formula I Mitogen-activated protein kinases (MAP) is a family of proline- directed serine/threonine kinases that activate their |